HCA Healthcare, Inc. $HCA Shares Purchased by Czech National Bank

Czech National Bank lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,201 shares of the company’s stock after buying an additional 1,569 shares during the period. Czech National Bank’s holdings in HCA Healthcare were worth $17,234,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Sumitomo Life Insurance Co. increased its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV grew its holdings in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC grew its stake in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after buying an additional 21 shares during the last quarter. Anchyra Partners LLC boosted its holdings in HCA Healthcare by 3.7% in the first quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after acquiring an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd increased its holdings in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $412.80 on Friday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The stock’s fifty day moving average price is $389.00 and its 200-day moving average price is $448.75. The company has a market cap of $89.37 billion, a P/E ratio of 13.82, a price-to-earnings-growth ratio of 1.42 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the firm posted $6.84 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. As a group, analysts expect that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Mizuho reduced their price objective on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research note on Tuesday, July 28th. KeyCorp reduced their price target on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday, July 27th. JPMorgan Chase & Co. cut their target price on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 19th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a report on Tuesday, July 7th. Finally, Truist Financial decreased their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $465.59.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.